Rocket
RCKT
Rocket (RCKT) news
Recent news
Rocket Pharmaceuticals announces closing of sale of rare pediatric disease priority review voucher for $180 million
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) has completed the sale of its Rare Pediatric Disease Priority Review Voucher (PRV) for $180 million, providing non-dilutive capital to support its cardiovascular gene therapy pipeline. The PRV was awarded following the FDA’s accelerated approval of…
AInvest Wire · Jun 12, 2026ImportantIsrael Defense Forces: Rocket falling near troops in southern Lebanon, no casualties reported
AInvest Wire · Jun 1, 2026ImportantIsrael Defense Forces: Rockets confirmed fired from Lebanon targeted frontline communities; rear command issued precautionary orders
AInvest Wire · Jun 1, 2026Rocket launched from southern Lebanon towards the Upper Galilee
AInvest Wire · May 30, 2026ImportantU.S. aerospace stocks rise premarket; Momentus +30%, Redwire ~23%, AST SpaceMobile and Rocket Lab >6% after NASA unveils three-phase lunar base roadmap for long-term lunar south pole habitation
AInvest Wire · May 27, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.